antibiotic agent; endogenous compound; ganciclovir; glass; heparin; immunoglobulin G; rituximab; steroid; adult; adult respiratory distress syndrome; antibiotic therapy; artificial ventilation; bacterial infection; bacterial pneumonia; blood culture; bronchopneumonia; cancer patient; case report; cell culture; clinical article; coinfection; conference abstract; coronavirus disease 2019; coughing; critically ill patient; cytology; Cytomegalovirus; cytopathogenic effect; drug therapy; dyspnea; female; hematologic malignancy; Herpes simplex virus; human; Human alphaherpesvirus 1; human tissue; immunocompromised patient; infectious agent; intensive care; invasive ventilation; lung disease; lung embolism; lung lavage; middle aged; mortality; mortality risk; nonhuman; oxygenation; Pneumocystis pneumonia; pneumonia; real time polymerase chain reaction; respiratory failure; respiratory tract disease; rheumatoid arthritis; risk factor; Severe acute respiratory syndrome coronavirus 2; sputum; thorax; tracheal aspiration procedure; treatment failure; tuberculosis